CYCLOGYL Drug Patent Profile
✉ Email this page to a colleague
When do Cyclogyl patents expire, and when can generic versions of Cyclogyl launch?
Cyclogyl is a drug marketed by Alcon Labs Inc and is included in three NDAs.
The generic ingredient in CYCLOGYL is cyclopentolate hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYCLOGYL?
- What are the global sales for CYCLOGYL?
- What is Average Wholesale Price for CYCLOGYL?
Summary for CYCLOGYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Drug Prices: | Drug price information for CYCLOGYL |
| DailyMed Link: | CYCLOGYL at DailyMed |
Recent Clinical Trials for CYCLOGYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanghai Eye Disease Prevention and Treatment Center | Phase 4 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Pontificia Universidad Catolica de Chile | Phase 4 |
US Patents and Regulatory Information for CYCLOGYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084109-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084110-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084108-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
